Skip to main content
Premium Trial:

Request an Annual Quote

Hoechst Marion Roussel Licenses Database from Genome Therapeutics

Premium

WALTHAM, Mass.--Genome Therapeutics here has licensed its proprietary microbial sequence database, PathoGenome, to Hoechst Marion Roussel. The pharmaceutical company will use the database to develop antiinfective products. Hoechst will pay annual subscription fees and royalties for nonexclusive access to the database. PathoGenome contains genomic sequence information from 24 microbial organisms assembled through Genome Therapeutics' pathogen genomics research and public-domain sources, as well as in-depth sequence analysis and proprietary bioinformatics tools.

Filed under

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.